May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Retinal Expression of IGF Binding Proteins
Author Affiliations & Notes
  • O. P. Aspegren
    Ophtalmology, Childrens Hospital Boston / Harvard Medical School, Boston, Massachusetts
  • C. Lofqvist
    Ophtalmology, The Queen Silvia Childre
  • A. Hellstrom
    Ophtalmology, The Queen Silvia Childre
  • J. Chen
    Ophtalmology, Childrens Hospital Boston / Harvard Medical School, Boston, Massachusetts
  • K. M. Connor
    Ophtalmology, Childrens Hospital Boston / Harvard Medical School, Boston, Massachusetts
  • K. L. Willett
    Ophtalmology, Childrens Hospital Boston / Harvard Medical School, Boston, Massachusetts
  • C. M. Aderman
    Ophtalmology, Childrens Hospital Boston / Harvard Medical School, Boston, Massachusetts
  • L. E. H. Smith
    Ophtalmology, Childrens Hospital Boston / Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  O.P. Aspegren, None; C. Lofqvist, None; A. Hellstrom, None; J. Chen, None; K.M. Connor, None; K.L. Willett, None; C.M. Aderman, None; L.E.H. Smith, None.
  • Footnotes
    Support  EY008670, EY017017, EY14811, V.Kann Rasmussen Foundation, Alcon Research Award, Lew Wasserman Merit Award (L.E.H.S.); F32 EY017789 (K.M.C.); Juvenile Diabetes Research Foundation fellowship (J.C.)
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 3443. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      O. P. Aspegren, C. Lofqvist, A. Hellstrom, J. Chen, K. M. Connor, K. L. Willett, C. M. Aderman, L. E. H. Smith; Retinal Expression of IGF Binding Proteins. Invest. Ophthalmol. Vis. Sci. 2008;49(13):3443. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Insulin-like growth factor I (IGF-I) has proven to be essential in preventing retinopathy of prematurity (ROP) by permitting normal retinal vascular growth in the first phase of ROP. Insulin-like growth factor binding protein-3 (IGFBP-3) has been shown to act independently of IGF-I in preventing oxygen-induced vessel loss and in promoting normal vascular regrowth after vascular destruction in the retina. Different IGF binding proteins are known, here we investigate six binding proteins and their expression profiles in the ischemic retina following oxygen-induced vessel loss.

Methods: : C57Bl/6 mice were put in 75% oxygen between postnatal day 7 (P7) and P12 in order to induce vessel loss. Retinas become hypoxic after return to room air at P12 following the hyperoxia-induced vaso-obliteration. The retinas were then collected at P8, P12, P15 and P17 and RNA was isolated for cDNA preparation. Real time RT PCR was used to quantify the gene expression for each binding protein at the different time points. Mice isolated in normoxia only were controls.

Results: : A marked induction (>7 fold) of IGFBP-3 mRNA expression during the hypoxic phase of retinopathy (P12-P17) was observed compared to normoxic controls. Also, the IGFBP-1 and IGFBP-6 mRNA expression levels were markedly elevated during this phase (>20 fold and 7 fold, respectively), compared to normoxic levels. The mRNA expression of IGFBP-2 and -5 was only moderately elevated with hypoxia (<1.25 fold) compared to normoxic controls. IGFBP-4 mRNA production was stable during oxygen induced retinopathy.

Conclusions: : The relative amounts of mRNA expression suggest that IGFBP-1, -3 and -6 do play an important role in the modulation of retinopathy in the oxygen-induced retinopathy model.

Keywords: growth factors/growth factor receptors • neovascularization • hypoxia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×